JP5731395B2 - 愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物 - Google Patents
愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物 Download PDFInfo
- Publication number
- JP5731395B2 JP5731395B2 JP2011542373A JP2011542373A JP5731395B2 JP 5731395 B2 JP5731395 B2 JP 5731395B2 JP 2011542373 A JP2011542373 A JP 2011542373A JP 2011542373 A JP2011542373 A JP 2011542373A JP 5731395 B2 JP5731395 B2 JP 5731395B2
- Authority
- JP
- Japan
- Prior art keywords
- ppm
- lipoic acid
- food composition
- effective amount
- administered
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241001465754 Metazoa Species 0.000 title claims description 39
- 239000000203 mixture Substances 0.000 title claims description 29
- 235000013305 food Nutrition 0.000 title claims description 26
- 230000000840 anti-viral effect Effects 0.000 title claims description 7
- 239000003963 antioxidant agent Substances 0.000 title description 9
- 230000002708 enhancing effect Effects 0.000 title description 5
- 230000003078 antioxidant effect Effects 0.000 title description 3
- 230000036039 immunity Effects 0.000 title description 2
- 235000019136 lipoic acid Nutrition 0.000 claims description 39
- 229960002663 thioctic acid Drugs 0.000 claims description 39
- 238000000034 method Methods 0.000 claims description 35
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 14
- 208000036142 Viral infection Diseases 0.000 claims description 13
- 230000009385 viral infection Effects 0.000 claims description 13
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 12
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 claims description 8
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 8
- 230000001965 increasing effect Effects 0.000 claims description 7
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 5
- 235000008100 Ginkgo biloba Nutrition 0.000 claims description 5
- 102000014150 Interferons Human genes 0.000 claims description 5
- 108010050904 Interferons Proteins 0.000 claims description 5
- 229930003268 Vitamin C Natural products 0.000 claims description 5
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 5
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims description 5
- 229940079322 interferon Drugs 0.000 claims description 5
- 235000019154 vitamin C Nutrition 0.000 claims description 5
- 239000011718 vitamin C Substances 0.000 claims description 5
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 claims description 4
- 108010024636 Glutathione Proteins 0.000 claims description 4
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 4
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 claims description 4
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 4
- 229960004308 acetylcysteine Drugs 0.000 claims description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 4
- 235000013734 beta-carotene Nutrition 0.000 claims description 4
- 239000011648 beta-carotene Substances 0.000 claims description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 4
- 229960002747 betacarotene Drugs 0.000 claims description 4
- 229940110767 coenzyme Q10 Drugs 0.000 claims description 4
- 229960003180 glutathione Drugs 0.000 claims description 4
- 235000012680 lutein Nutrition 0.000 claims description 4
- 239000001656 lutein Substances 0.000 claims description 4
- 229960005375 lutein Drugs 0.000 claims description 4
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 4
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims description 4
- 230000001404 mediated effect Effects 0.000 claims description 4
- 235000011649 selenium Nutrition 0.000 claims description 4
- 239000011669 selenium Substances 0.000 claims description 4
- 229910052711 selenium Inorganic materials 0.000 claims description 4
- 229960003080 taurine Drugs 0.000 claims description 4
- 229930003802 tocotrienol Natural products 0.000 claims description 4
- 239000011731 tocotrienol Substances 0.000 claims description 4
- 235000019148 tocotrienols Nutrition 0.000 claims description 4
- 229940068778 tocotrienols Drugs 0.000 claims description 4
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims description 4
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 4
- 235000011201 Ginkgo Nutrition 0.000 claims description 3
- 235000010469 Glycine max Nutrition 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 3
- 229960001570 ademetionine Drugs 0.000 claims description 3
- 230000005860 defense response to virus Effects 0.000 claims description 3
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 claims description 3
- 150000002515 isoflavone derivatives Chemical class 0.000 claims description 3
- 235000008696 isoflavones Nutrition 0.000 claims description 3
- 229940091258 selenium supplement Drugs 0.000 claims description 3
- AGBQKNBQESQNJD-UHFFFAOYSA-M lipoate Chemical compound [O-]C(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-M 0.000 claims 12
- 241000218628 Ginkgo Species 0.000 claims 2
- AGBQKNBQESQNJD-UHFFFAOYSA-N lipoic acid Chemical compound OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 33
- 241000282472 Canis lupus familiaris Species 0.000 description 21
- 235000005911 diet Nutrition 0.000 description 11
- 230000037213 diet Effects 0.000 description 11
- 241000282326 Felis catus Species 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 5
- 230000007423 decrease Effects 0.000 description 4
- 230000003923 mental ability Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 241000282465 Canis Species 0.000 description 3
- 244000194101 Ginkgo biloba Species 0.000 description 3
- 235000020940 control diet Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 102000016557 gamma Subunit Interferon-Stimulated Gene Factor 3 Human genes 0.000 description 3
- 108010067667 gamma Subunit Interferon-Stimulated Gene Factor 3 Proteins 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 231100000252 nontoxic Toxicity 0.000 description 3
- 230000003000 nontoxic effect Effects 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 244000000626 Daucus carota Species 0.000 description 2
- 235000002767 Daucus carota Nutrition 0.000 description 2
- 206010012289 Dementia Diseases 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 101100198353 Mus musculus Rnasel gene Proteins 0.000 description 2
- 108010044012 STAT1 Transcription Factor Proteins 0.000 description 2
- 102000006381 STAT1 Transcription Factor Human genes 0.000 description 2
- 108010081691 STAT2 Transcription Factor Proteins 0.000 description 2
- 102000004265 STAT2 Transcription Factor Human genes 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000300264 Spinacia oleracea Species 0.000 description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 description 2
- 235000009754 Vitis X bourquina Nutrition 0.000 description 2
- 235000012333 Vitis X labruscana Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 235000014787 Vitis vinifera Nutrition 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- 230000028993 immune response Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 229930003799 tocopherol Natural products 0.000 description 2
- 235000010384 tocopherol Nutrition 0.000 description 2
- 239000011732 tocopherol Substances 0.000 description 2
- 229960001295 tocopherol Drugs 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 2
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 102100027962 2-5A-dependent ribonuclease Human genes 0.000 description 1
- 108010000834 2-5A-dependent ribonuclease Proteins 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 235000017647 Brassica oleracea var italica Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 108010001857 Cell Surface Receptors Proteins 0.000 description 1
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 102000006992 Interferon-alpha Human genes 0.000 description 1
- 108010047761 Interferon-alpha Proteins 0.000 description 1
- 102000003996 Interferon-beta Human genes 0.000 description 1
- 108090000467 Interferon-beta Proteins 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 102000001253 Protein Kinase Human genes 0.000 description 1
- 238000010802 RNA extraction kit Methods 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- GLEVLJDDWXEYCO-UHFFFAOYSA-N Trolox Chemical compound O1C(C)(C(O)=O)CCC2=C1C(C)=C(C)C(O)=C2C GLEVLJDDWXEYCO-UHFFFAOYSA-N 0.000 description 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 description 1
- 108020000999 Viral RNA Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 238000000540 analysis of variance Methods 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229960004203 carnitine Drugs 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol group Chemical group [C@@H]1(CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)[C@H](C)CCCC(C)C HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 235000009569 green tea Nutrition 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 108060006633 protein kinase Proteins 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 235000003687 soy isoflavones Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 230000006656 viral protein synthesis Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/121—Heterocyclic compounds containing oxygen or sulfur as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/158—Fatty acids; Fats; Products containing oils or fats
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Zoology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Physiology (AREA)
- Virology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Description
[0004] 有意レベルの少なくとも1種類の抗酸化剤が成体の愛玩用ペットの食事中に存在するか、あるいはペットにその食事以外に与えられることにより、高齢の愛玩用ペットの精神能力の衰退開始を阻止し、および/または成体の愛玩用ペットの精神能力をさらに高齢になるまで維持することができる。
[0008] 本発明は、愛玩動物がウイルス感染症に抵抗または対抗する能力を増強する方法であって、愛玩動物に愛玩動物がウイルス感染症に抵抗または対抗する能力を増強するのに有効な量のリポ酸を含む食物組成物を投与することを含む方法を包含する。
[0010] 特定の態様において、有効量は少なくとも約50ppmである。
[0012] 特定の態様において、有効量は約100ppm〜約600ppmである。
[0013] 特定の態様において、有効量は約100ppm〜約200ppmである。
[0015] 特定の態様において、愛玩動物はネコである。
[0016] 特定の態様において、有効量は愛玩動物において先天性(innate)抗ウイルス活性を増強するのに有効である。
[0018] 特定の態様において、リポ酸を含むペットフード組成物を少なくとも30日間投与する。
[0020] 特定の態様において、リポ酸を含むペットフード組成物を1日1回投与する。
[0023] 特定の態様において、有効量は少なくとも約50ppmである。
[0024] 特定の態様において、有効量は少なくとも約100ppmである。
[0026] 特定の態様において、有効量は約100ppm〜約200ppmである。
[0027] 特定の態様において、愛玩動物はイヌである。
[0029] 特定の態様において、リポ酸を含むペットフード組成物を少なくとも15日間投与する。
[0031] 特定の態様において、リポ酸を含むペットフード組成物を少なくとも45日間投与する。
[0033] 成体の愛玩用ペット、たとえばイヌ類およびネコ類に与える食事は、その年齢の動物に与える標準的な普通食である。下記は1〜6歳のイヌ類のための典型的な食事である:
[0042] セレンは約0.1から約5ppmまでで使用できる。
[0043] ルテイン:少なくとも約5ppmを使用できる。
[0045] コエンザイムQ10:少なくとも約25ppmを使用できる。
[0046] S−アデノシルメチオニン:少なくとも約50ppmを使用できる。
[0048] ダイズイソフラボン類:少なくとも約25ppmを使用できる。
[0049] N−アセチルシステイン:少なくとも約50ppmを使用できる。
[0051] イチョウ:少なくとも50ppmの抽出物を使用できる。
[0052] 以下は、ORAC(Oxygen radical absorbing capacity、酸素ラジカル吸収能)含量の高い原料成分である:ホウレンソウ搾りかす、トマト搾りかす、柑橘類果肉、ブドウ搾りかす、ニンジン顆粒、ブロッコリ、緑茶、イチョウ、およびトウモロコシグルテンミール。食事に1%の含有率(トウモロコシのように低ORAC成分については合計5%の置換)として添加した場合、それらは食事全体のORAC含量を増大させ、これらの成分を含有する食事を食べた動物の血漿のORAC含量を増大させた。好ましくは、乾燥物質のグラム当たりORAC含量>25.mu.moleをもついずれかのTrolox均等成分を、1%で他の4種類の1%成分と組み合わせて合計5%を食事に添加すれば使用できる。
[0053] 実験条件
[0054] 20匹のイヌに30日間給餌した。10匹にはAAFCOレベルの対照食、他の10匹のイヌには150ppmのアルファ−リポ酸を含有するAAFCOレベルの対照食を与えた。30日間の終了時に各イヌから全血試料をPaxgenチューブに採集した。
Claims (24)
- 愛玩動物がウイルス感染症に抵抗または対抗する能力を増強する方法であって、その必要がある愛玩動物に、愛玩動物がウイルス感染症に抵抗または対抗する能力を増強するのに有効な量の、リポ酸、ならびにビタミンE、ビタミンC、ベータ−カロテン、セレン、ルテイン、トコトリエノール類、コエンザイムQ10、S−アデノシルメチオニン、タウリン、ダイズイソフラボン類、N−アセチルシステイン、グルタチオンおよびイチョウのうち1種類以上を含む食物組成物を投与することを含み、その際、愛玩動物がウイルス感染症に抵抗または対抗する能力を増強するリポ酸の有効量が少なくとも約25ppmである方法。
- 有効量が少なくとも約50ppmである、請求項1に記載の方法。
- 有効量が少なくとも約100ppmである、請求項1に記載の方法。
- 有効量が約100ppm〜約600ppmである、請求項1に記載の方法。
- 有効量が約100ppm〜約200ppmである、請求項1に記載の方法。
- 愛玩動物がイヌである、請求項1に記載の方法。
- 愛玩動物がネコである、請求項1に記載の方法。
- 有効量が愛玩動物において内的抗ウイルス活性を増強するのに有効である、請求項1に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも15日間投与する、請求項1に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも30日間投与する、請求項1に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも45日間投与する、請求項1に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも1日1回投与する、請求項1に記載の方法。
- 愛玩動物においてウイルス感染症を処置する方法であって、その必要がある愛玩動物に有効量の、リポ酸、ならびにビタミンE、ビタミンC、ベータ−カロテン、セレン、ルテイン、トコトリエノール類、コエンザイムQ10、S−アデノシルメチオニン、タウリン、ダイズイソフラボン類、N−アセチルシステイン、グルタチオンおよびイチョウのうち1種類以上を含む食物組成物を投与することを含み、その際、リポ酸の有効量が少なくとも約25ppmである方法。
- 有効量が少なくとも約50ppmである、請求項13に記載の方法。
- 有効量が少なくとも約100ppmである、請求項13に記載の方法。
- 有効量が約100ppm〜約600ppmである、請求項13に記載の方法。
- 有効量が約100ppm〜約200ppmである、請求項13に記載の方法。
- 愛玩動物がイヌである、請求項13に記載の方法。
- 愛玩動物がネコである、請求項13に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも15日間投与する、請求項13に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも30日間投与する、請求項13に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも45日間投与する、請求項13に記載の方法。
- リポ酸を含むペットフード組成物を少なくとも1日1回投与する、請求項13に記載の方法。
- ペットフード組成物がインターフェロン仲介による抗ウイルス応答を誘導する、請求項1〜23のいずれか1項に記載の方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12292008P | 2008-12-16 | 2008-12-16 | |
US61/122,920 | 2008-12-16 | ||
PCT/US2009/068230 WO2010077933A1 (en) | 2008-12-16 | 2009-12-16 | Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2012511933A JP2012511933A (ja) | 2012-05-31 |
JP2012511933A5 JP2012511933A5 (ja) | 2013-01-17 |
JP5731395B2 true JP5731395B2 (ja) | 2015-06-10 |
Family
ID=41611113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011542373A Active JP5731395B2 (ja) | 2008-12-16 | 2009-12-16 | 愛玩動物において抗ウイルス性免疫を増強する際に使用するための、抗酸化剤を含有する食物組成物 |
Country Status (8)
Country | Link |
---|---|
US (3) | US20110256118A1 (ja) |
EP (1) | EP2364098B1 (ja) |
JP (1) | JP5731395B2 (ja) |
CN (1) | CN102245032B (ja) |
BR (1) | BRPI0923454A2 (ja) |
CA (1) | CA2746769C (ja) |
RU (1) | RU2489898C2 (ja) |
WO (1) | WO2010077933A1 (ja) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10842809B2 (en) | 2016-12-16 | 2020-11-24 | Hills Pet Nutrition, Inc. | Pet food compositions |
CN108041314A (zh) * | 2018-01-10 | 2018-05-18 | 佛山市所能网络有限公司 | 一种具有通乳作用的松鼠饲料及其制备方法 |
CN111568921A (zh) * | 2020-04-20 | 2020-08-25 | 奥格生物技术(六安)有限公司 | 一种促进冠状病毒患者康复的新型硒制剂配方及其制备方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS60184011A (ja) * | 1984-03-02 | 1985-09-19 | Itaru Yamamoto | 免疫調節剤 |
US6133323A (en) * | 1997-04-09 | 2000-10-17 | The Iams Company | Process for enhancing immune response in animals using β-carotene as a dietary supplement |
NZ527924A (en) * | 1999-01-29 | 2005-01-28 | Mars Uk Ltd | Antioxidant compositions and methods for companion animals |
US20020076470A1 (en) * | 2000-10-31 | 2002-06-20 | Colgate-Palmolive Company | Composition and method |
US20030190314A1 (en) * | 2001-01-30 | 2003-10-09 | The Lauridsen Group | Methods and compositions of treatment for modulating the immune system of animals |
RU2280448C2 (ru) * | 2002-11-10 | 2006-07-27 | Институт биофизики клетки РАН | Композиция с антиоксидантными свойствами и способ лечения болезней млекопитающих |
CN1835765A (zh) * | 2003-08-13 | 2006-09-20 | 霍华德·J·史密斯及同仁控股有限公司 | 治疗病毒感染的方法 |
JP5138380B2 (ja) * | 2004-11-24 | 2013-02-06 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 動物における免疫応答を増大させる方法 |
WO2007009111A1 (en) * | 2005-07-14 | 2007-01-18 | Hill's Pet Nutrition, Inc. | Method for prolonging the life of animals |
CN1895671B (zh) * | 2005-12-08 | 2012-11-28 | 淮北辉克药业有限公司 | 治疗病毒型肝病的复方制剂 |
-
2009
- 2009-12-16 CN CN200980151644.8A patent/CN102245032B/zh not_active Expired - Fee Related
- 2009-12-16 BR BRPI0923454-3A patent/BRPI0923454A2/pt not_active Application Discontinuation
- 2009-12-16 RU RU2011129309/13A patent/RU2489898C2/ru not_active IP Right Cessation
- 2009-12-16 CA CA2746769A patent/CA2746769C/en active Active
- 2009-12-16 US US13/140,143 patent/US20110256118A1/en not_active Abandoned
- 2009-12-16 JP JP2011542373A patent/JP5731395B2/ja active Active
- 2009-12-16 EP EP09793420.2A patent/EP2364098B1/en active Active
- 2009-12-16 WO PCT/US2009/068230 patent/WO2010077933A1/en active Application Filing
-
2017
- 2017-01-19 US US15/410,351 patent/US20170128415A1/en not_active Abandoned
-
2019
- 2019-03-26 US US16/364,535 patent/US20190216772A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2746769C (en) | 2014-04-29 |
RU2489898C2 (ru) | 2013-08-20 |
US20170128415A1 (en) | 2017-05-11 |
WO2010077933A1 (en) | 2010-07-08 |
EP2364098A1 (en) | 2011-09-14 |
US20190216772A1 (en) | 2019-07-18 |
EP2364098B1 (en) | 2016-10-12 |
JP2012511933A (ja) | 2012-05-31 |
CN102245032A (zh) | 2011-11-16 |
CA2746769A1 (en) | 2010-07-08 |
AU2009333237A1 (en) | 2011-06-23 |
CN102245032B (zh) | 2014-12-10 |
BRPI0923454A2 (pt) | 2015-07-28 |
RU2011129309A (ru) | 2013-01-27 |
US20110256118A1 (en) | 2011-10-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5743903B2 (ja) | 愛玩動物においてインターフェロン仲介による抗ウイルス活性を増強するための方法 | |
AU2007216836B2 (en) | Composition and method | |
US8592478B2 (en) | Antioxidant-containing food composition | |
JP2007202565A (ja) | 組成物及び方法 | |
US20190216772A1 (en) | Antioxidant-Containing Food Composition for Use in Enhancing Antiviral Immunity in Companion Animals | |
US20090156658A1 (en) | Antioxidant-Containing Food Composition For Use In Inhibiting Histamine Pathways In Companion Animals | |
JP5791515B2 (ja) | 愛玩動物においてヒスタミン関連経路を阻害する際に使用するための、抗酸化剤を含有する食物組成物 | |
AU2009333237B2 (en) | Antioxidant-containing food composition for use in enhancing antiviral immunity in companion animals | |
ZA200303746B (en) | Aged companion pet diet. | |
ZA200303739B (en) | Pet food composition and method. | |
JP2010142237A (ja) | 組成物及び方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20121112 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121114 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20131010 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131031 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20140130 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20140206 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20150311 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20150409 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5731395 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |